Community-based Individualized Homeopathic Rehabilitation in Post COVID-19 Patients

NCT ID: NCT05715554

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-06

Study Completion Date

2023-01-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A growing number of studies identify a spectrum of persistent symptoms experienced by COVID-19 patients for months after recovery. Symptoms include cough, fatigue, dyspnea, pain, and brain fog (cognitive impairment, including confusion and memory loss), which have a negative impact on daily activities. Homoeopathic practitioners from around the world have documented a number of successful cases of Post COVID treatment. Even though evidence from practice-based research is limited, the purpose of the current study was to evaluate the effect of individualized homoeopathy treatment on post-COVID syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-COVID Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Homeopathy Group

Individualized Homeopathy Treatment provided by homeopathic physicians

Group Type EXPERIMENTAL

Homeopathy

Intervention Type OTHER

Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.

Standard Group

Usual care provided by primary care physicians were followed by patients in the standard group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Homeopathy

Individualized homoeopathic medicines on impregnated lactose pellets was prescribed based on totality of physical, emotional, and mental symptoms.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Confirmed COVID-19 history
* Persistent respiratory symptoms for more than three months after COVID-19
* Able to provide informed consent

Exclusion Criteria

* Presence of respiratory issues without COVID-19 diagnosis
* On complementary and Alternative Treatment
* Symptoms of infection
* Pregnancy or Breastfeeding
* Cognitive impairment
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gyansanjeevani India

UNKNOWN

Sponsor Role collaborator

Collaborative Homeopathy Research Network

UNKNOWN

Sponsor Role collaborator

Innowage Limited

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sadhana Sharma

Role: PRINCIPAL_INVESTIGATOR

Gyansanjeevani India

Vesna Marinković

Role: STUDY_DIRECTOR

Collaborative Homeopathy Research Network

Neha Sharma

Role: STUDY_CHAIR

Innowage Limited

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gyansanjeevani India

Dausa, Rajasthan, India

Site Status

Gyansanjeevani India

Jaipur, Rajasthan, India

Site Status

Gyansanjeevani India

Mandāwa, Rajasthan, India

Site Status

Gyansanjeevani India

Sawai Madhopur, Rajasthan, India

Site Status

Gyansanjeevani India

Sīkar, Rajasthan, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I-G-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Homeopathic Drug Proving Trial
NCT01061229 COMPLETED PHASE1